These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7576912)

  • 21. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
    Ebenbichler C; Westervelt P; Carrillo A; Henkel T; Johnson D; Ratner L
    AIDS; 1993 May; 7(5):639-46. PubMed ID: 7686374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coreceptor usage of HIV-1 after deletion of Gly317-Pro318-Gly319 motif in the gp120 V3 loop.
    Su J; Vahlne A
    AIDS; 2000 Jan; 14(1):91-2. PubMed ID: 10714573
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.
    Majerle A; Pristovsek P; Mancek-Keber M; Jerala R
    J Biol Chem; 2011 Jul; 286(29):26228-37. PubMed ID: 21636577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel membrane-bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1.
    Kido H; Fukutomi A; Katunuma N
    Biomed Biochim Acta; 1991; 50(4-6):781-9. PubMed ID: 1686971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
    Gu R; Westervelt P; Ratner L
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein.
    Avril LE; Di Martino-Ferrer M; Barin F; Gauthier F
    FEBS Lett; 1993 Feb; 317(1-2):167-72. PubMed ID: 8428626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages.
    Benjouad A; Seddiki N; Ylisastigui L; Gluckman JC
    AIDS Res Hum Retroviruses; 1997 Feb; 13(3):219-26. PubMed ID: 9115808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5.
    Morikis D; Rizos AK; Spandidos DA; Krambovitis E
    Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.
    Andrianov AM; Kornoushenko YV; Kashyn IA; Kisel MA; Tuzikov AV
    J Biomol Struct Dyn; 2015; 33(5):1051-66. PubMed ID: 24942968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.
    Maeda Y; Matsushita S; Hattori T; Murakami T; Takatsuki K
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2049-54. PubMed ID: 1493053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1--co-receptors binding.
    Jiang S
    Nat Med; 1997 Apr; 3(4):367-8. PubMed ID: 9095160
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
    Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L
    Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.